For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.
Synthetic peptide corresponding to C terminus of human CD11b
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Our Abpromise guarantee covers the use of ab52478 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ICC/IF||Use at an assay dependent concentration. PubMed: 24505439|
|IHC-FoFr||Use at an assay dependent concentration.|
|WB||1/20000 - 1/50000. Predicted molecular weight: 128 kDa.|
|ICC||1/100 - 1/250.|
|Flow Cyt||1/20 - 1/50.|
|IHC-P||Use at an assay dependent concentration.|
This image is courtesy of an anonymous Abreview
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"